Skip to main content

Table 2 Number and proportion of patients and patient-months by patient characteristics

From: Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study

Characteristics

Patients (%)

Patient months (%)

Patient type

Existing patient

300 (91%)

3506 (95%)

New patients

26 (8%)

153 (4%)

Gender

Male

192 (59%)

2148 (58%)

Female

134 (41%)

1511 (41%)

Age

<50 years

284 (87%)

3172 (86%)

50+ years

42 (13%)

487 (13%)

Risk factor

COHP

133 (41%)

1501 (41%)

Heterosexual

63 (19%)

721 (20%)

MSM/Bisexual

95 (29%)

1067 (29%)

IDU

18 (5%)

185 (5%)

Other

8 (2%)

96 (3%)

Unknown

9 (3%)

89 (2%)

Late diagnosis

No

135 (41%)

1535 (42%)

Unknown

77 (23%)

840 (23%)

Yes

114 (35%)

1284 (35%)

Years since diagnosis

11+ years ago

95 (29%)

1107 (30%)

6-10 years ago

107 (33%)

1231 (34%)

1-5 years ago

100 (30%)

1140 (31%)

diagnosed in 2012

17 (5%)

105 (3%)

Lowest CD4 count in 2012 (cells/μl)

500+

168 (51%)

1894 (52%)

350-499

85 (26%)

973 (26%)

200-349

52 (16%)

581 (16%)

50-199

14 (4%)

146 (4%)

<50

7 (2%)

65 (2%)

Treatment and viral load statusb

On HAART, suppressed

211 (64%)

2469 (67%)

On HAART, not suppressed

37 (11%)

438 (12%)

On HAART, unable to determine status

7 (2%)

75 (2%)

Started/Stopped HAART

49 (15%)

440 (12%)

Not on HAART

22 (7%)

237 (6%)

Overall

 

326 (100%)

3659(100%)

  1. COHP, person from a country of high prevalence with no other identifiable risk factor available. IDU, current/former injecting drug user. Late diagnosis defined as CD4 count < 350 cells/μl at diagnosis or AIDS defining illness at diagnosis. “On HAART” means the patient was on HAART for the entire duration of the study, “suppressed” was defined as all viral loads in 2012 < 50 copies/ml, with one test result of 50–499 copies/ml allowed if previous and subsequent viral load results were < 50 copies/ml.